Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D W Boulware

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Clinics in Dermatology|July 1, 1994
Oncogenes, growth factors, and matrix in the pathogenesis of systemic sclerosisS Gay, D W Boulware, R E Gay
Postgraduate Medicine|February 1, 1990
The fibromyalgia syndrome. Could you recognize and treat it?D W Boulware, L D Schmid, M Baron
Postgraduate Medicine|January 1, 1993
Pulmonary manifestations of rheumatic diseaseS L Byrd, B A Case, D W Boulware
The Journal of Rheumatology|August 1, 1992
Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in sclerodermaC A Feghali, D W Boulware, L S Levy
Clinical Reviews in Allergy|May 1, 1985
Pulmonary manifestations of the rheumatic diseasesD W Boulware, D N Weissman, N J Doll
Molecular Immunology|December 1, 1985
Cyanogen bromide cleaves Fc fragments of pooled human IgG at both methionine and tryptophan residuesD W Boulware, P D Goldsworthy, F A Nardella, et al.
Autoimmunity|January 1, 1994
Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosisC A Feghali, K L Bost, D W Boulware, et al.
Clinical Immunology and Immunopathology|May 1, 1992
Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblastsC A Feghali, K L Bost, D W Boulware, et al.
The Journal of Rheumatology|August 1, 1992
Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with sclerodermaC A Feghali, K L Bost, D W Boulware, et al.
Autoimmunity|January 1, 1993
Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosisC A Feghali, D W Boulware, J A Ferriss, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Clinics in Dermatology|July 1, 1994
Oncogenes, growth factors, and matrix in the pathogenesis of systemic sclerosisS Gay, D W Boulware, R E Gay
Postgraduate Medicine|February 1, 1990
The fibromyalgia syndrome. Could you recognize and treat it?D W Boulware, L D Schmid, M Baron
Postgraduate Medicine|January 1, 1993
Pulmonary manifestations of rheumatic diseaseS L Byrd, B A Case, D W Boulware
The Journal of Rheumatology|August 1, 1992
Mechanisms of pathogenesis in scleroderma. II. Effects of serum and conditioned culture medium on fibroblast function in sclerodermaC A Feghali, D W Boulware, L S Levy
Clinical Reviews in Allergy|May 1, 1985
Pulmonary manifestations of the rheumatic diseasesD W Boulware, D N Weissman, N J Doll
Molecular Immunology|December 1, 1985
Cyanogen bromide cleaves Fc fragments of pooled human IgG at both methionine and tryptophan residuesD W Boulware, P D Goldsworthy, F A Nardella, et al.
Autoimmunity|January 1, 1994
Control of IL-6 expression and response in fibroblasts from patients with systemic sclerosisC A Feghali, K L Bost, D W Boulware, et al.
Clinical Immunology and Immunopathology|May 1, 1992
Human recombinant interleukin-4 induces proliferation and interleukin-6 production by cultured human skin fibroblastsC A Feghali, K L Bost, D W Boulware, et al.
The Journal of Rheumatology|August 1, 1992
Mechanisms of pathogenesis in scleroderma. I. Overproduction of interleukin 6 by fibroblasts cultured from affected skin sites of patients with sclerodermaC A Feghali, K L Bost, D W Boulware, et al.
Autoimmunity|January 1, 1993
Expression of c-myc, c-myb, and c-sis in fibroblasts from affected and unaffected skin of patients with systemic sclerosisC A Feghali, D W Boulware, J A Ferriss, et al.
Pageof 3